Novenda Technologies Secures $6.1M to Reshape Dental Manufacturing with 3D Printing
July 14, 2025, 3:38 pm
Novenda Technologies secured $6.1 million in new funding. This Dutch innovator spearheads dental product manufacturing. Its multi-material 3D printing revolutionizes prosthetics. The technology creates comfortable, natural-looking nightguards and dentures. It combines hard and soft materials in a single print. This eliminates manual assembly and extensive post-processing. Novenda's solution meets rising demand in large dental labs. It enhances efficiency and affordability in digital dentistry. The company targets expansion across Europe and the US. This marks a significant industry shift.
Novenda Technologies, a Dutch innovator, recently announced a significant funding round. The company secured $6.1 million. This capital injection aims to scale its multi-material 3D printing technology. It targets dental product manufacturing. This investment fuels a major shift in how dental prosthetics are made. The future of digital dentistry looks different.
The funding round was led by Brightlands Venture Partners. KBC Focus Fund, Borski Fund, and Limburg Business Development Fund/LIOF also participated. Angel investors contributed. An Innovation Credit from RVO also provided support. This diverse investor group signals strong confidence in Novenda’s vision.
Novenda Technologies launched in 2019. Founders Klaas Wiertzema, Petra Doelman, and Joost Anne Veerman drove its creation. Intensive market research guided their initial steps. Collaboration with dental professionals shaped their early development. This foundation built a company ready for disruption.
By 2021, Novenda achieved a key milestone. Its first printer was installed at the High Tech Campus in Eindhoven. This unit produced its first multi-material print. Proprietary software and materials powered this breakthrough. This marked the start of intensive development. It validated their core concept.
A successful proof of concept followed in 2023. Novenda demonstrated its capabilities for nightguards and dentures. These products showcase the technology's potential. They offer superior comfort and aesthetics. This prepares the company for broader market deployment.
Novenda’s full-stack technology represents a fundamental change. It enables manufacturing of sophisticated dental products. These products combine hard materials for protection. Soft materials provide comfort. All components are produced in a single piece. This unified approach eliminates complex assembly steps.
Traditional methods involve extensive manual work. Post-processing is often cumbersome. Novenda’s platform streamlines this. It seamlessly combines multiple materials. A single print run completes the process. Water-soluble supports are used. These supports dissolve with simple tap water. This radically simplifies workflow.
A crucial innovation lies in Novenda’s smart print modes. These modes achieve precise layer control. No mechanical rollers are needed. Competing systems often rely on rollers. Rollers can cause ink contamination. They restrict color capabilities. Novenda bypasses these limitations. This ensures superior quality and versatility.
The platform boasts an advanced color management algorithm. It offers unlimited color possibilities. Only a few base colors are required. This ensures natural-looking prosthetics. Mechanical properties remain strong. Products maintain durability. They will not break during use.
Efficiency is a core advantage. The system produces up to 15 nightguards per hour. It can also produce 8 dentures per hour. This makes it ideal for mid-size and large dental laboratories. High throughput directly translates to increased productivity. Labs can serve more patients faster.
Novenda’s LD100 printer is a one-time investment. However, it operates exclusively with Novenda’s proprietary materials. This ensures consistent quality. It also guarantees biocompatibility. This model generates recurring revenue for the company. It maintains strict quality standards for end-users.
The timing of Novenda’s solution is critical. The dental industry is undergoing a major digital transformation. Oral scanners now frequently replace manual impressions. This digital shift has revolutionized data capture. Yet, manufacturing techniques often lag behind. They still require substantial manual intervention.
Novenda’s automated platform addresses this gap. It aligns manufacturing with digital workflows. This is particularly relevant as dental technicians become scarcer. Their expertise also commands higher costs. Automation provides a much-needed solution. It enhances lab profitability and efficiency.
In many countries, a trend towards centralized manufacturing facilities is emerging. This trend is driven by the challenges of traditional methods. Novenda’s automated platform will significantly impact these facilities. It enables scalable, high-precision production. Minimal waste and post-processing are key benefits.
This technology elevates quality standards for dental products. It also enhances affordability for patients. Many patients struggle to afford current alternatives. Novenda’s solution expands access to superior dental care. This drives the industry toward a more sustainable and equitable future.
Novenda Technologies has assembled a formidable team. Fifteen experts contribute to its success. Their expertise spans physics, chemistry, material science, and software engineering. This multidisciplinary approach fosters deep innovation. It ensures robust product development.
The company protects its innovations rigorously. Multiple patents secure its intellectual property. More patents are in the pipeline. This commitment to IP safeguards its competitive edge. It reinforces its position as a market leader.
Early industry feedback has been exceptionally positive. Experts praise Novenda’s night guards. Surface finish and aesthetic appearance receive high marks. Some describe them as "the best." Others suggest multi-material jetting is "the future" in dentistry. Such endorsements underscore its disruptive potential.
Looking ahead, Novenda plans strategic expansion. The platform will extend to other dental applications. It will eventually enter new markets. These markets require individualized mass manufacturing. Novenda’s technology is uniquely suited for such demands.
The immediate focus remains clear. Novenda aims to deploy its technology across Europe and the US. Large and mid-size dental labs are the primary target. Its high-throughput, automated solution addresses growing demand. Novenda is poised to redefine digital dentistry on a global scale. This is a new era for dental prosthetics.
Novenda Technologies, a Dutch innovator, recently announced a significant funding round. The company secured $6.1 million. This capital injection aims to scale its multi-material 3D printing technology. It targets dental product manufacturing. This investment fuels a major shift in how dental prosthetics are made. The future of digital dentistry looks different.
The funding round was led by Brightlands Venture Partners. KBC Focus Fund, Borski Fund, and Limburg Business Development Fund/LIOF also participated. Angel investors contributed. An Innovation Credit from RVO also provided support. This diverse investor group signals strong confidence in Novenda’s vision.
Novenda Technologies launched in 2019. Founders Klaas Wiertzema, Petra Doelman, and Joost Anne Veerman drove its creation. Intensive market research guided their initial steps. Collaboration with dental professionals shaped their early development. This foundation built a company ready for disruption.
By 2021, Novenda achieved a key milestone. Its first printer was installed at the High Tech Campus in Eindhoven. This unit produced its first multi-material print. Proprietary software and materials powered this breakthrough. This marked the start of intensive development. It validated their core concept.
A successful proof of concept followed in 2023. Novenda demonstrated its capabilities for nightguards and dentures. These products showcase the technology's potential. They offer superior comfort and aesthetics. This prepares the company for broader market deployment.
Novenda’s full-stack technology represents a fundamental change. It enables manufacturing of sophisticated dental products. These products combine hard materials for protection. Soft materials provide comfort. All components are produced in a single piece. This unified approach eliminates complex assembly steps.
Traditional methods involve extensive manual work. Post-processing is often cumbersome. Novenda’s platform streamlines this. It seamlessly combines multiple materials. A single print run completes the process. Water-soluble supports are used. These supports dissolve with simple tap water. This radically simplifies workflow.
A crucial innovation lies in Novenda’s smart print modes. These modes achieve precise layer control. No mechanical rollers are needed. Competing systems often rely on rollers. Rollers can cause ink contamination. They restrict color capabilities. Novenda bypasses these limitations. This ensures superior quality and versatility.
The platform boasts an advanced color management algorithm. It offers unlimited color possibilities. Only a few base colors are required. This ensures natural-looking prosthetics. Mechanical properties remain strong. Products maintain durability. They will not break during use.
Efficiency is a core advantage. The system produces up to 15 nightguards per hour. It can also produce 8 dentures per hour. This makes it ideal for mid-size and large dental laboratories. High throughput directly translates to increased productivity. Labs can serve more patients faster.
Novenda’s LD100 printer is a one-time investment. However, it operates exclusively with Novenda’s proprietary materials. This ensures consistent quality. It also guarantees biocompatibility. This model generates recurring revenue for the company. It maintains strict quality standards for end-users.
The timing of Novenda’s solution is critical. The dental industry is undergoing a major digital transformation. Oral scanners now frequently replace manual impressions. This digital shift has revolutionized data capture. Yet, manufacturing techniques often lag behind. They still require substantial manual intervention.
Novenda’s automated platform addresses this gap. It aligns manufacturing with digital workflows. This is particularly relevant as dental technicians become scarcer. Their expertise also commands higher costs. Automation provides a much-needed solution. It enhances lab profitability and efficiency.
In many countries, a trend towards centralized manufacturing facilities is emerging. This trend is driven by the challenges of traditional methods. Novenda’s automated platform will significantly impact these facilities. It enables scalable, high-precision production. Minimal waste and post-processing are key benefits.
This technology elevates quality standards for dental products. It also enhances affordability for patients. Many patients struggle to afford current alternatives. Novenda’s solution expands access to superior dental care. This drives the industry toward a more sustainable and equitable future.
Novenda Technologies has assembled a formidable team. Fifteen experts contribute to its success. Their expertise spans physics, chemistry, material science, and software engineering. This multidisciplinary approach fosters deep innovation. It ensures robust product development.
The company protects its innovations rigorously. Multiple patents secure its intellectual property. More patents are in the pipeline. This commitment to IP safeguards its competitive edge. It reinforces its position as a market leader.
Early industry feedback has been exceptionally positive. Experts praise Novenda’s night guards. Surface finish and aesthetic appearance receive high marks. Some describe them as "the best." Others suggest multi-material jetting is "the future" in dentistry. Such endorsements underscore its disruptive potential.
Looking ahead, Novenda plans strategic expansion. The platform will extend to other dental applications. It will eventually enter new markets. These markets require individualized mass manufacturing. Novenda’s technology is uniquely suited for such demands.
The immediate focus remains clear. Novenda aims to deploy its technology across Europe and the US. Large and mid-size dental labs are the primary target. Its high-throughput, automated solution addresses growing demand. Novenda is poised to redefine digital dentistry on a global scale. This is a new era for dental prosthetics.